Rev1 wbdR tagged vaccines against Brucella ovis
Sheep brucellosis is a worldwide extended disease caused by B. melitensis and B. ovis, two species respectively carrying smooth or rough lipopolysaccharide. Vaccine B. melitensis Rev1 is used against B. melitensis and B. ovis but induces an anti-smooth-lipopolysaccharide response interfering with B....
Huvudupphovsmän: | Aragón-Aranda, B. (Beatriz), Miguel, M.J. (María Jesús) de, Martinez-Gomez, E. (Estrella), Zuñiga-Ripa, A. (Amaia), Salvador-Bescós, M. (Miriam), Moriyon, I. (Ignacio), Muñoz, P. (Pilar), Raquel |
---|---|
Materialtyp: | info:eu-repo/semantics/article |
Språk: | eng |
Publicerad: |
Springer Science and Business Media LLC
2021
|
Ämnen: | |
Länkar: | https://hdl.handle.net/10171/61550 |
Liknande verk
Liknande verk
-
Correction: Rev1 wbdR tagged vaccines against Brucella ovis
av: Aragón-Aranda, B. (Beatriz), et al.
Publicerad: (2023) -
GFP tagging of Brucella melitensis Rev1 allows the identification of vaccinated sheep
av: Zabalza-Barangua, A. (Ana), et al.
Publicerad: (2022) -
Stability of poly(epsilon-caprolactone) microparticles containing Brucella ovis antigens as a vaccine delivery system against brucellosis.
av: Estevan, M. (M.), et al.
Publicerad: (2011) -
Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model
av: Monreal, D. (Daniel), et al.
Publicerad: (2013) -
Epitope identification for subunit vaccine design: application to prophylactic vaccines against SARS-CoV-2 and therapeutic vaccines against cancer
av: Aparicio-De-la-Torre, B. (Belén), et al.
Publicerad: (2023)